Related Experiment Video
Updated: Aug 30, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Aortic valve replacement in patients aged 50 to 69 years: Analysis using Korean National Big Data
Min-Seok Kim1, Hae Rim Kim2, Seung Hyun Lee3
1Department of Thoracic and Cardiovascular Surgery, Cardiovascular Center, Myongji Hospital, Hanyang University College of Medicine, Seoul, Korea.
Insights
For patients aged 50-69 undergoing aortic valve replacement (AVR), bioprosthetic valves showed similar long-term survival and cardiac mortality rates compared to mechanical valves. Reoperations were more common with bioprosthetic valves, while bleeding was more frequent with mechanical valves.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomaterials Science
Background:
- Aortic valve replacement (AVR) is a critical procedure for managing aortic valve disease.
- The choice between mechanical valves and bioprosthetic valves involves balancing long-term durability against risks of anticoagulation and bleeding.
Purpose of the Study:
- To compare clinical outcomes and long-term survival after isolated AVR in patients aged 50-69 years.
- To evaluate the comparative effectiveness of mechanical versus bioprosthetic valves in this patient cohort.
Main Methods:
- A retrospective study using the Korean National Health Information Database (2002-2018).
- Included 4732 patients aged 50-69 years who underwent isolated AVR.
- Propensity score-matched analysis created two groups of 1429 patients each: bioprosthetic (Group B) and mechanical (Group M) valves.
Main Results:
- Overall survival rates at 5 and 10 years were similar between Group B (87.8%, 75.2%) and Group M (91.2%, 76.7%).
- Freedom from cardiac death rates at 5 and 10 years were also comparable (Group B: 95.6%, 92.4%; Group M: 96.0%, 92.1%).
- Reoperations were significantly higher in Group B (p=0.007), while major bleeding was higher in Group M (p=0.039).
Conclusions:
- Bioprosthetic valves demonstrate comparable long-term survival and cardiac mortality-free survival to mechanical valves in patients aged 50-69 undergoing isolated AVR.
- The choice of valve type influences specific complication risks, with bioprosthetic valves associated with higher reoperation rates and mechanical valves with increased bleeding risk.
Background:
The aim of this study was to compare the clinical outcomes and long-term survival in patients who underwent isolated aortic valve replacement (AVR) with mechanical versus bioprosthetic valves.
Methods:
Patients aged 50-69 years who had undergone AVR from 2002 to 2018 were identified and their characteristics were collected from Korean National Health Information Database formed by the National Health Insurance Service, Republic of Korea. Of the 5792 patients, 1060 patients were excluded due to missing values on characteristics. Of the 4732 study patients, 1945 patients (41.1%) had received bioprosthetic valves (Group B) and 2787 patients (58.9%) had received mechanical valves (Group M). A propensity score-matched analysis was performed to match 1429 patients in each group. Data on mortality, cardiac mortality, reoperations, cerebrovascular accidents, and bleeding complications were obtained.
Results:
The overall survival rates at 5 and 10 years postoperatively were 87.8% and 75.2% in the matched Group B and 91.2% and 76.7% in the matched Group M, respectively (p = .140). Freedom from cardiac death rates at postoperative 5 and 10 years were 95.6% and 92.4% in the matched Group B and 96.0% and 92.1% in the matched Group M, respectively (p = .540). The cumulative incidence of reoperation was higher in the matched Group B than in the matched Group M (p = .007), and the cumulative incidence of major bleeding was higher in the matched Group M than in the matched Group B (p = .039).
Conclusion:
In patients aged 50-69 years who underwent isolated AVR, the patients who received bioprosthetic valves showed similar cardiac mortality-free survival and long-term survival rates to the patients who received mechanical valves.
More Related Videos
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction

